Accession Number:

ADA523553

Title:

Varicella Zoster Virus Meningitis Complicating Sodium Stibogluconate Treatment for Cutaneous Leishmaniasis

Descriptive Note:

Journal article

Corporate Author:

WALTER REED ARMY INST OF RESEARCH WASHINGTON DC DIV OF MEDICINE

Report Date:

2006-01-01

Pagination or Media Count:

3.0

Abstract:

U.S. Armed Forces, with more than 700 cutaneous cases diagnosed in servicemen deployed in support of Operation Iraqi Freedom. Treatment options available for patients infected with Old World cutaneous leishmaniasis range from observation for patients with mild disease to the administration of parenteral sodium stibogluconate for patients with more significant lesions. Sodium stibogluconate is known to result in several predictable side-effects including arthralgias myalgias 58, elevated pancreatic enzymes 97, elevated liver-associated enzymes 67, headache 22, and hematologic suppression 44. Herpes zoster temporally associated with the administration of sodium stibogluconate has also been reported, perhaps secondary to transient lymphopenia. In this report, we describe a patient who developed aseptic meningitis and herpes zoster secondary to varicella zoster virus VZV.

Subject Categories:

  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE